"2-
Application 4255/DELNP/2006 published 2007-07-13, filed 2006-07-24
The present invention relates to novel compounds selected from 2-(3substitutedaryl)amino-4-aryl-thiazoles that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant tyrosine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic, and degenerative disorders. More particularly, these compounds are potent and selective c-kit inhibitors.
Applicant
1)AB SCIENCE
:3, AVENUE GEORGE V, F-75008 PARIS, FRANCE France
Inventor
1)MOUSSY ALAIN 2)CIUFOLINI MARCO 3)WERMUTH CAMILLE 4)GIETHLEN BRUNO
International Info
Classification: C07D 417/04
Publication Number: WO 2005/073225
Application Date: 2005-01-28
Priority Information
60/540,064 U.S.A. 2004-01-30